Active, Not Recruiting
Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options
NCT02650401
- Conditions
- Adenocarcinoma, Adenocarcinoma, Papillary, Brain Diseases, +59 more
- Locations
-
- University of California San Diego La Jolla, California, United States
- UCSF Benioff Children's Hospital San Francisco, California, United States
- Children's Hospital Colorado Aurora, Colorado, United States
- Egleston Children's Hospital at Emory University Atlanta Atlanta, Georgia, United States